Dr. Jonathan Kaufman, Chief Executive Officer and Co-Founder of Lipella, said, "We are pleased to renew our collaboration ...

AnaptysBio Inc. (NASDAQ:ANAB) announced that its investigational drug, rosnilimab, demonstrated a best-in-disease profile in ...

Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025.

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today announced publication of results from the Phase 2a SATURN study in Thorax.

Allegrow Biotech, Editact Therapeutics and Syngular Technology are finalists in the start-up pitch competition, 2025 EQT ...

BAPTC&B have taken initiative to arrange workshop on the basics of CRISPR-Cas9 technology called the “Precision Gene Editing ...

Let’s face it—navigating the life sciences job market or finding the right talent for your company can feel like wandering through a maze blindfolded. SIRE Life Sciences changes the game entirely.

Is the right time to invest in some top-performing US penny stocks? Here's a look at some of the top-performing ones from ...

On June 5, 2025, the House Science and Technology Subcommittees on Energy and on Research and Technology will hold a joint ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...